Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A

Infection and Immunity

Volumn 71, Issue 12, 2003, Pages 6864-6870

  Hall, Andrea E ^a   Domanski, Paul J ^a   Patel, Pratiksha R ^a   Vernachio, John H ^a   Syribeys, Peter J ^a   Gorovits, Elena L ^a   Johnson, Michael A ^b   Ross, Julia M ^b   Hutchins, Jeff T ^a   Patti, Joseph M ^a  

^a Inhibitex Inc   (United States)

^b University of Marylandw Baltimore County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; MICROBIAL SURFACE COMPONENT RECOGNIZING ADHESIVE MATRIX MOLECULE; PROTEIN; PROTEIN CLUMPING FACTOR A; RECOMBINANT ANTIBODY; RECOMBINANT MONOCLONAL ANTIBODY[12-9]; RECOMBINANT PROTEIN CLUMPING FACTOR A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL PROTECTION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL ADHESION; COAGULASE; HUMANS; HYBRIDOMAS; IMMUNIZATION; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

EID: 10744232525     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.12.6864-6870.2003     Document Type: Article

References (51)

1. Abraham, E., A. Anzueto, G. Gutierrez, S. Tessler, G. San Pedro, R. Wunderink, A. Dal Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. B. Light, L. Poole, R. Allred, J. Constant, J. Pennington, and S. Porter. 1998. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 351:929-933.
2. Anonymous. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531-537.
3. Anonymous. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567.
4. Bayer, A. S., P. M. Sullam, M. Ramos, C. Li, A. L. Cheung, and M. R. Yeaman. 1995. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect. Immun. 63:3634-3641.
5. Booth, M. C., L. M. Pence, P. Mahasreshti, M. C. Callegan, and M. S. Gilmore. 2001. Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect. Immun. 69:345-352.
6. Brennan, F. R., T. D. Jones, M. Longstaff, S. Chapman, T. Bellaby, B. Smith, F. Xu, W. D. Hamilton, and J. I. Flock. 1999. Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 17:1846-1857.
7. Chuard, C., P. Vaudaux, F. A. Waldvogel, and D. P. Lew. 1993. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob. Agents Chemother. 37:625-632.
8. Cohen, J., and J. Carlet. 1996. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit. Care Med. 24:1431-1440.
9. Cooke, R. P., and C. T. Jenkins. 1997. Comparison of commercial slide agglutination kits with a tube coagulase test for the rapid identification of Staphylococcus aureus from blood culture. J. Clin. Pathol. 50:164-166.
10. Day, N. P., C. E. Moore, M. C. Enright, A. R. Berendt, J. M. Smith, M. F. Murphy, S. J. Peacock, B. G. Spratt, and E. J. Feil. 2001. A link between virulence and ecological abundance in natural populations of Staphylococcus aureus. Science 292:114-116.
11. Dickinson, R. B., J. A. Nagel, D. McDevitt, T. J. Foster, R. A. Proctor, and S. L. Cooper. 1995. Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect. Immun. 63:3143-3150.
12. Fattom, A. I., and R. Naso. 1996. Staphylococcal vaccines: a realistic dream. Ann. Med. 28:43-46.
13. Fattom, A. I., J. Sarwar, A. Ortiz, and R. Naso. 1996. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect. Immun. 64:1659-1665.
14. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488.
15. Johnson, S., S. D. Griego, D. S. Pfarr, M. L. Doyle, R. Woods, D. Carlin, G. A. Prince, S. Koenig, J. F. Young, and S. B. Dillon. 1999. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZ19. J. Infect. Dis. 180:35-40.
16. Josefsson, E., O. Hartford, L. O'Brien, J. M. Patti, and T. Foster. 2001. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184:1572-1580.
17. Josefsson, E., K. W. McCrea, D. Ni Eidhin, D. O'Connell, J. Cox, M. Hook, and T. J. Foster. 1998. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology 144(Pt. 12):3387-3395.
18. Keller, M. A., and E. R. Stiehm. 2000. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 13:602-614.
19. Krilov, L. R. 2002. Palivizumab in the prevention of respiratory syncytial virus disease. Expert Opin. Biol. Ther. 2:763-769.
20. Li, Z. J., N. Mohamed, and J. M. Ross. 2000. Shear stress affects the kinetics of Staphylococcus aureus adhesion to collagen. Biotechnol. Prog. 16:1086-1090.
21. McCloskey, P. V., R. C. Straube, C. Sanders, S. M. Smith, and C. R. Smith. 1994. Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 121:1-5.
22. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1995. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol. Microbiol. 16:895-907.
23. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248,
24. McDevitt, D., T. Nanavaty, K. House-Pompeo, E. Bell, N. Turner, L. McIntire, T. Foster, and M. Hook. 1997. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur. J. Biochem. 247:416-424.
25. McDevitt, D., P. Vaudaux, and T. J. Foster. 1992. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect. Immun. 60:1514-1523.
26. Mohamed, N., T. R. Rainier, Jr., and J. M. Ross. 2000. Novel experimental study of receptor-mediated bacterial adhesion under the influence of fluid shear. Biotechnol. Bioeng. 68:628-636.
27. Mohamed, N., M. A. Teeters, J. M. Patti, M. Hook, and J. M. Ross. 1999. Inhibition of Staphylococcus aureus adherence to collagen under dynamic conditions. Infect. Immun. 67:589-594.
28. Mohamed, N., L. Visai, P. Speziale, and J. M. Ross. 2000. Quantification of Staphylococcus aureus cell surface adhesins using flow cytometry. Microb. Pathog. 29:357-361.
29. Moreillon, P., J. M. Entenza, P. Francioli, D. McDevitt, T. J. Foster, P. Francois, and P. Vaudaux. 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:4738-4743.
30. Morin, C. A., and J. L. Hadler. 2001. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas. 1998. J. Infect. Dis. 184:1029-1034.
31. Ni Eidhin, D., S. Perkins, P. Francois, P. Vaudaux, M. Hook, and T. J. Foster. 1998. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol. Microbiol. 30:245-257.
32. Nilsson, I. M., J. M. Patti, T. Bremell, M. Hook, and A. Tarkowski. 1998. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J. Clin. Investig. 101:2640-2649.
33. Patti, J. M., B. L. Allen, M. J. Mcgavin, and M. Hook. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617.
34. Peacock, S. J., C. E. Moore, A. Justice, M. Kantzanou, L. Story, K. Mackie, G. O'Neill, and N. P. Day. 2002. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70: 4987-4996.
35. Perrillo, R. P. 2000. Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts. Clin. Transplant. 14(Suppl. 2):25-28.
36. Personne, P., M. Bes, G. Lina, F. Vandenesch, Y. Brun, and J. Etienne. 1997. Comparative performances of six agglutination kits assessed by using typical and atypical strains of Staphylococcus aureus. J. Clin. Microbiol. 35:1138-1140.
37. Que, Y. A., J. A. Haefliger, P. Francioli, and P. Moreillon. 2000. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect. Immun. 68:3516-3522.
38. Rennermalm, A., Y. H. Li, L. Bohaufs, C. Jarstrand, A. Brauner, F. R. Brennan, and J. I. Flock. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19:3376-3383.
39. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27: 887-892.
40. Rozalska, B., and T. Wadstrom. 1993. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Scand. J. Immunol. 37:575-580.
41. Sawyer, L. A. 2000. Antibodies for the prevention and treatment of viral diseases. Antiviral Res. 47:57-77.
42. Sefton, A. M. 2002. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs 62:557-566.
43. Shinefield, H., S. Black, A. Fattom, G. Horwith, S. Rasgon, J. Ordonez, H. Yeoh, D. Law, J. B. Robbins, R. Schneerson, L. Muenz, S. Fuller, J. Johnson, B. Fireman, H. Alcorn, and R. Naso. 2002. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346: 491-496.
44. Siboo, I. R., A. L. Cheung, A. S. Bayer, and P. M. Sullam. 2001. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect. Immun. 69:3120-3127.
45. Skurnik, M., P. Mikkola, P. Toivanen, and R. Tertti. 1996. Passive immunization with monoclonal antibodies specific for lipopolysaccharide (LPS) O-side chain protects mice against intravenous Yersinia enterocolitica serotype O:3 infection. APMIS 104:598-602.
46. Snydman, D. R. 2001. Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation. Transplant. Infect. Dis. 3(Suppl. 2):6-13.
47. Strahilevitz, J., and E. Rubinstein. 2002. Novel agents for resistant gram-positive infections - a review. Int. J. Infect. Dis. 6(Suppl. 1):S38-S46.
48. Stutzmann Meier, P., J. M. Entenza, P. Vaudaux, P. Francioli, M. P. Glauser, and P. Moreillon. 2001. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect. Immun. 69:657-664.
49. Switalski, L. M., J. M. Patti, W. Butcher, A. G. Gristina, P. Speziale, and M. Hook. 1993. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7:99-107.
50. Wilkerson, M., S. McAllister, J. M. Miller, B. J. Heiter, and P. P. Bourbeau. 1997. Comparison of five agglutination tests for identification of Staphylococcus aureus. J. Clin. Microbiol. 35:148-151.
51. Yokoyama, W. 1995. Production of monoclonal antibodies: induction of immune responses, p. 2.5.4-2.5.8. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology, vol. 1. Wiley and Sons, Hoboken, N.J.